SCHEDULE 1SUBSTANCES WHICH IF INCLUDED IN MEDICINAL PRODUCTS MAKE THOSE PRODUCTS PRESCRIPTION ONLY MEDICINES AND EXEMPTIONS FROM RESTRICTIONS ON THE SALE AND SUPPLY OF PRESCRIPTION ONLY MEDICINES
Words in Sch. 1 inserted (19.1.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1999 (S.I. 1999/3463), arts. 1(1), 2(c)
Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(a)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), art. 1(1), Sch.
Sch. 1 entries inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(g)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1997 (S.I. 1997/2044), art. 1(1), Sch. 1
Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(a)
Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(a)
Sch. 1: entries renumbered (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(a)
Words in Sch. 1 omitted (16.9.1998) by virtue of The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(b)
Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(a)
Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(a)
Word in Sch. 1 substituted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(b)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(c)(ii)
Words in Sch. 1 substituted (16.9.1998) by virtue ofThe Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(c)(i)
Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(h)
Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(e)
Word in Sch. 1 substituted (16.9.1997) by The Prescription Only Medicines (Human Use) Amendment Order 1997 (S.I. 1997/2044), arts. 1(1), 2(a)
Words in Sch. 1 revoked (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(a)
Sch. 1 entries inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(f)
Sch. 1 entries inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(e)
Sch. 1 entries inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(b)
Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(a)
Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(d)
Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(c)
Words in Sch. 1 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(e)(i)
Word in Sch. 1 substituted (19.1.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1999 (S.I. 1999/3463), arts. 1(1), 2(a)
Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(e)
Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(b)
Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(f)(i)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(f)(ii)
Words in Sch. 1 omitted (16.9.1998) by virtue of The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(f)(iii)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(i)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(ii)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(iii)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(iv)
Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(c)
Sch. 1: entries renumbered (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(c)
Words in Sch. 1 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(a)
Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(c)
Words in Sch. 1 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 3(a)
Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(d)
Word in Sch. 1 inserted (13.8.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(e)(ii)
Word in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(g)(ii)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(g)(i)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(g)(iii)
Words in Sch. 1 inserted (19.1.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1999 (S.I. 1999/3463), arts. 1(1), 2(b)
Sch. 1 entries inserted (1.1.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000 (S.I. 2000/3231), arts. 1(1), 2
Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(e)(i)
Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(e)(ii)
Words in Sch. 1 revoked (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(c)
Words in Sch. 1 substituted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(b)
Words in Sch. 1 substituted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(b)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(h)
Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(c)(i)
Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(c)(ii)
Words in Sch. 1 substituted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(c)(iii)
Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(d)
Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(f)(i)
Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(f)(ii)
Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(f)(iii)
Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(d)(ii)
Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(d)(i)
Words in Sch. 1 added (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(c)
Words in Sch. 1 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(d)
Sch. 1: entries renumbered (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(d)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(d)(i)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(d)(ii)
Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(d)(iii)
Words in Sch. 1 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 3(b)
Sch. 1: entries renumbered (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(e)
Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(e)
Sch. 1 entries inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(e)
Words in Sch. 1 omitted (16.9.1997) by virtue of The Prescription Only Medicines (Human Use) Amendment Order 1997 (S.I. 1997/2044), arts. 1(1), 2(b)
Sch. 1 entries re-numbered (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(g)
Sch. 1 entries inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(g)
Exemptions from the restrictions on the sale and supply of prescription only medicines | |||||
|---|---|---|---|---|---|
Column 1 | Column 2 | Column 3 | Column 4 | Column 5 | |
Substance | Maximum strength | Route of administration, use or pharmaceutical form | Treatment limitations | Maximum quantity | |
F49Acamprosate | |||||
Acarbose | |||||
Acebutolol Hydrochloride | |||||
F49Aceclofenac | |||||
Acemetacin | |||||
Acetarsol | |||||
Acetazolamide | |||||
Acetazolamide Sodium | |||||
Acetohexamide | |||||
Acetylcholine Chloride | 0.2 per cent | External | |||
Acetylcysteine | |||||
Acipimox | |||||
Aciclovir | 5.0 per cent | External | Container or package containing not more than 2g of medicinal product | ||
For treatment of herpes simplex virus infections of the lips and face (Herpes labialis) | |||||
Acitretin | |||||
Aclarubicin Hydrochloride | |||||
Aconite | 1.3 per cent | External | |||
Acrivastine | 24 mg (MDD) | Container or package containing not more than 240mg of Acrivastine | |||
Acrosoxacin | |||||
Actinomycin C | |||||
Actinomycin D | |||||
F46Adapalene | |||||
Adenosine | |||||
Adrenaline | (1) By inhaler | ||||
(2) External F69(except ophthalmic) | |||||
Adrenaline Acid Tartrate | (1) By inhaler | ||||
(2) External | |||||
Adrenaline Hydrochloride | (1) By inhaler | ||||
(2) External | |||||
Adrenocortical Extract | |||||
Albendazole | |||||
Alclofenac | |||||
Alclometasone Dipropionate | |||||
Alcuronium Chloride | |||||
Aldesleukin | |||||
Aldosterone | |||||
F49Alendronate Sodium | |||||
Alfacalcidol | |||||
Alfuzosin Hydrochloride | |||||
Allergen Extracts | |||||
Allopurinol | |||||
Allyloestrenol | |||||
F34Aloxiprin | (1) 620 mg | (1) Non-effervescent tablets and capsules | (1) The quantity sold or supplied in one container or package shall not exceed 32 | ||
The quantity of non-effervescent tablets, capsules or a combination of both sold or supplied to a person at any one time shall not exceed 100 | |||||
(2) All preparations other than non-effervescent tablets or capsules | |||||
Alphadolone Acetate | |||||
Alphaxalone | |||||
Alprenolol | |||||
Alprenolol Hydrochloride | |||||
Alprostadil | |||||
Alseroxylon | |||||
F46Altretamine | |||||
Amantadine Hydrochloride | |||||
Ambenonium Chloride | |||||
Ambutonium Bromide | |||||
Amcinonide | |||||
Ametazole Hydrochloride | |||||
Amethocaine | Non-ophthalmic use | ||||
Amethocaine Gentisate | Non-ophthalmic use | ||||
Amethocaine Hydrochloride | Non-ophthalmic use | ||||
Amikacin Sulphate | |||||
Amiloride Hydrochloride | |||||
Aminocaproic Acid | |||||
Aminoglutethimide | |||||
Aminopterin Sodium | |||||
Amiodarone Hydrochloride | |||||
Amiphenazole Hydrochloride | |||||
F77Amisulpride | |||||
Amitriptyline | |||||
Amitriptyline Embonate | |||||
Amitriptyline Hydrochloride | |||||
Amlodipine Besylate | |||||
Ammonium Bromide | |||||
Amodiaquine Hydrochloride | |||||
Amorolfine Hydrochloride | |||||
Amoxapine | |||||
Amoxycillin | |||||
Amoxycillin Sodium | |||||
Amoxycillin Trihydrate | |||||
Amphomycin Calcium | |||||
Amphotericin | |||||
Ampicillin | |||||
Ampicillin Sodium | |||||
Ampicillin Trihydrate | |||||
Amsacrine | |||||
Amygdalin | |||||
Amyl Nitrite | |||||
Amylocaine Hydrochloride | Non-ophthalmic use | ||||
F49Anastrozole | |||||
Ancrod | |||||
Androsterone | |||||
Angiotensin Amide | |||||
Anistreplase | |||||
Anterior Pituitary Extract | |||||
Antimony Barium Tartrate | |||||
Antimony Dimercaptosuccinate | |||||
Antimony Lithium Thiomalate | |||||
Antimony Pentasulphide | |||||
Antimony Potassium Tartrate | |||||
Antimony Sodium Tartrate | |||||
Antimony Sodium Thioglycollate | |||||
Antimony Sulphate | |||||
Antimony Trichloride | |||||
Antimony Trioxide | |||||
Antimony Trisulphide | |||||
Apiol | |||||
Apomorphine | |||||
Apomorphine Hydrochloride | |||||
F46Apraclonidine Hydrochloride | |||||
Aprotinin | |||||
Arecoline Hydrobromide | |||||
Argipressin | |||||
Aristolochia | |||||
Aristolochia Clematitis | |||||
Aristolochia Contorta | |||||
Aristolochia Debelis | |||||
Aristolochia Fang-chi | |||||
Aristolochia Manshuriensis | |||||
Aristolochia Serpentaria | |||||
Arsenic | |||||
Arsenic Triiodide | |||||
Arsenic Trioxide | |||||
Arsphenamine | |||||
F19Aspirin |
|
|
| ||
|
| ||||
|
| ||||
Astemizole | F22. . . | F22. . . | F22. . . | ||
F22. . . | |||||
F22. . . | |||||
Atenolol | |||||
Atracurium Besylate | |||||
Atropine | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 300mcg (MD) | ||||
1mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Atropine Methobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 400mcg (MD) | ||||
1.3mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Atropine Methonitrate | Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 400mcg (MD) | ||||
1.3mg (MDD) | |||||
Atropine Oxide Hydrochloride | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 360mcg (MD) | ||||
1.2mg (MDD) 3 | |||||
(2) External (except ophthalmic) | |||||
Atropine Sulphate | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 360mcg (MD) | ||||
1.2mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Auranofin | |||||
Azapropazone | |||||
Azathioprine | |||||
Azathioprine Sodium | |||||
Azelaic Acid | |||||
Azelastine Hydrochloride | For nasal administration | 140mcg per nostril (MD) | Container or package containing not more than 5,040mcg of Azelastine Hydrochloride | ||
For the treatment of seasonal allergic rhinitis F52or perennial allergic rhinitis | 280mcg per nostril (MDD) | ||||
For use in adults and children not less than F535 years | |||||
As a non-aerosol, aqueous form | |||||
Azidocillin Potassium | |||||
Azithromycin | |||||
Azlocillin Sodium | |||||
Aztreonam | |||||
Bacampicillin Hydrochloride | |||||
Bacitracin | |||||
Bacitracin Methylene Disalicylate | |||||
Bacitracin Zinc | |||||
Baclofen | |||||
F77Balsalazide Sodium | |||||
Bambuterol Hydrochloride | |||||
Barium Carbonate | |||||
Barium Chloride | |||||
Barium Sulphide | |||||
Beclamide | |||||
Beclomethasone | |||||
Beclomethasone Dipropionate | For nasal administration (non-aerosol) | 100mcg per nostril (MD) | Container or package containing not more than F3920,000 mcg of Beclomethasone Dipropionate | ||
For the prevention and treatment of allergic rhinitis | 200 mcg per nostril (MDD) | ||||
F24For a maximum period of 3 months | |||||
F23For use in persons aged 18 years and over | |||||
Belladonna Herb | (1) Internal | (1) 1mg of the alkaloids (MDD) | |||
(2) External | |||||
Belladonna Root | (1) Internal | (1) 1mg of the alkaloids (MDD) | |||
(2) External | |||||
Bemegride | |||||
Bemegride Sodium | |||||
Benapryzine Hydrochloride | |||||
Bendrofluazide | |||||
Benethamine Penicillin | |||||
Benoxaprofen | |||||
Benperidol | |||||
F77Benserazide | |||||
Benserazide Hydrochloride | |||||
Bentiromide | |||||
Benzathine Penicillin | |||||
Benzbromarone | |||||
Benzhexol Hydrochloride | |||||
Benzilonium Bromide | |||||
Benzocaine | Any use except ophthalmic use | ||||
Benzoctamine Hydrochloride | |||||
Benzoyl Peroxide | 10.0 per cent | External | |||
N-Benzoyl Sulphanilamide | |||||
Benzquinamide | |||||
Benzquinamide Hydrochloride | |||||
Benzthiazide | |||||
Benztropine Mesylate | |||||
Benzylpenicillin Calcium | |||||
Benzylpenicillin Potassium | |||||
Benzylpenicillin Sodium | |||||
Beractant | |||||
Betahistine Hydrochloride | |||||
Betamethasone | |||||
Betamethasone Adamantoate | |||||
Betamethasone Benzoate | |||||
Betamethasone Dipropionate | |||||
Betamethasone Sodium Phosphate | |||||
Betamethasone Valerate | |||||
Betaxolol Hydrochloride | |||||
Bethanechol Chloride | |||||
Bethanidine Sulphate | |||||
Bezafibrate | |||||
F46Bicalutamide | |||||
Biperiden Hydrochloride | |||||
Biperiden Lactate | |||||
Bismuth Glycollylarsanilate | |||||
Bisoprolol Fumarate | |||||
Bleomycin | |||||
Bleomycin Sulphate | |||||
Bretylium Tosylate | |||||
F77Brimonidine Tartrate | |||||
Bromhexine Hydrochloride | |||||
Bromocriptine Mesylate | |||||
Bromperidol | |||||
Bromvaletone | |||||
Brotizolam | |||||
Budesonide | For nasal administration | 200mcg per nostril (MD) | Container or package containing not more than 10mg of Budesonide | ||
For the prevention or treatment of seasonal allergic rhinitis | F24For a maximum period of 3 months | ||||
200 mcg per nostril (MDD) | |||||
F23For use in persons aged 18 years and over | |||||
As a non-aerosol, aqueous form | |||||
Bufexamac | |||||
Bumetanide | |||||
Buphenine Hydrochloride | 6mg (MD) | ||||
18mg (MDD) | |||||
Bupivacaine | Any use except ophthalmic use | ||||
Bupivacaine Hydrochloride | Any use except ophthalmic use | ||||
Buserelin Acetate | |||||
Buspirone Hydrochloride | |||||
Busulphan | |||||
Butacaine Sulphate | Any use except ophthalmic use | ||||
Butorphanol Tartrate | |||||
Butriptyline Hydrochloride | |||||
F64Cabergoline | |||||
Calcipotriol | |||||
F46Calcipotriol Hydrate | |||||
Calcitonin | |||||
Calcitriol | |||||
Calcium Amphomycin | |||||
Calcium Benzamidosalicylate | |||||
Calcium Bromide | |||||
Calcium Bromidolactobionate | |||||
Calcium Carbimide | |||||
Calcium Folinate | |||||
Calcium Metrizoate | |||||
Calcium Sulphaloxate | |||||
F43Candesartan Cilexetil | |||||
Candicidin | |||||
Canrenoic Acid | |||||
Cantharidin | 0.01 per cent | External | |||
Capreomycin Sulphate | |||||
Captopril | |||||
Carbachol | |||||
Carbamazepine | |||||
Carbaryl | |||||
F77Carbasalate Calcium | |||||
Carbenicillin Sodium | |||||
Carbenoxolone Sodium | (1) Pellet | (1) 5mg (MD) | |||
25mg (MDD) | |||||
(2) 2.0 per cent | (2) Gel | ||||
(3) 1.0 per cent | (3) Granules for mouthwash in adults and children not less than 12 years | (3) 20mg (MD) | (3) Container or package containing not more than F1560mg of Carbenoxolone Sodium | ||
80mg (MDD) | |||||
Carbidopa | |||||
Carbimazole | |||||
Carbocisteine | |||||
Carbon Tetrachloride | |||||
Carboplatin | |||||
Carboprost Trometamol | |||||
Carbuterol Hydrochloride | |||||
Carfecillin Sodium | |||||
Carindacillin Sodium | |||||
Carisoprodol | |||||
Carmustine | |||||
Carperidine | |||||
Carteolol Hydrochloride | |||||
Cefaclor | |||||
Cefadroxil | |||||
Cefazedone Sodium | |||||
F77Cefdinir | |||||
Cefixime | |||||
Cefodizime Sodium | |||||
Cefotaxime Sodium | |||||
Cefoxitin Sodium | |||||
Cefpodoxime Proxetil | |||||
F64Cefprozil | |||||
Cefsulodin Sodium | |||||
Ceftazidime | |||||
Ceftizoxime Sodium | |||||
Ceftriaxone Sodium | |||||
Cefuroxime Axetil | |||||
Cefuroxime Sodium | |||||
Celiprolol Hydrochloride | |||||
Cephalexin | |||||
Cephalexin Sodium | |||||
Cephaloridine | |||||
Cephalothin Sodium | |||||
Cephamandole Nafate | |||||
Cephazolin Sodium | |||||
Cephradine | |||||
Cerium Oxalate | |||||
Cerivastatin | |||||
F77Cerivastatin Sodium | |||||
Ceruletide Diethylamine | |||||
Cetirizine Hydrochloride | 10mg (MDD) | F78. . . | |||
Chenodeoxycholic Acid | |||||
Chloral Hydrate | External | ||||
Chlorambucil | |||||
Chloramphenicol | |||||
Chloramphenicol Cinnamate | |||||
Chloramphenicol Palmitate | |||||
Chloramphenicol Sodium Succinate | |||||
Chlorhexadol | |||||
Chlormadinone Acetate | |||||
Chlormerodrin | |||||
Chlormethiazole | |||||
Chlormethiazole Edisylate | |||||
Chlormezanone | |||||
Chloroform20 | (1) 5.0 per cent | (1) Internal | |||
(2) External | |||||
Chloroquine Phosphate | Prophylaxis of malaria | ||||
Chloroquine Sulphate | Prophylaxis of malaria | ||||
Chlorothiazide | |||||
Chlorotrianisene | |||||
Chlorphenoxamine Hydrochloride | |||||
Chlorpromazine | |||||
Chlorpromazine Embonate | |||||
Chlorpromazine Hydrochloride | |||||
Chlorpropamide | |||||
Chlorprothixene | |||||
Chlorprothixene Hydrochloride | |||||
Chlortetracycline | |||||
Chlortetracycline Calcium | |||||
Chlortetracycline Hydrochloride | |||||
Chlorthalidone | |||||
Chlorzoxazone | |||||
Cholestyramine | |||||
Ciclacillin | |||||
Ciclobendazole | |||||
Cilastatin Sodium | |||||
Cilazapril | |||||
Cimetidine | (a) For the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity and for the prophylaxis of meal-induced heartburn | (a) 200mg (MD) | |||
800mg (MDD) | |||||
For a maximum period of 14 days | |||||
(b) For the prophylactic management of nocturnal heartburn by a single dose taken at night | (b) 100mg (MD) to be taken as a single dose at night | ||||
For a maximum period of 14 days | |||||
Cimetidine Hydrochloride | |||||
Cinchocaine | 3.0 per cent | Non-ophthalmic use | |||
Cinchocaine Hydrochloride | Equivalent of 3.0 per cent of Cinchocaine | Non-ophthalmic use | |||
Cinchophen | |||||
Cinoxacin | |||||
Ciprofibrate | |||||
Ciprofloxacin | |||||
Ciprofloxacin Hydrochloride | |||||
Cisapride | |||||
Cisplatin | |||||
F46Citalopram Hydrobromide | |||||
Clarithromycin | |||||
Clavulanic Acid | |||||
Clidinium Bromide | |||||
Clindamycin | |||||
Clindamycin Hydrochloride | |||||
Clindamycin Palmitate Hydrochloride | |||||
Clindamycin Phosphate | |||||
Clioquinol | (1) External (other than treatment of mouth ulcers) | ||||
(2) 35mg | (2) Treatment of mouth ulcers | (2) 350mg (MDD) | |||
Clobetasol Propionate | |||||
Clobetasone Butyrate | F760.05 per cent | F76Cream for use in adults and in children aged 12 years and over, for external use for the short term symptomatic treatment and control of patches of eczema and dermatitis (excluding seborrhoeic dermatitis) | F76Container or package containing not more than 15g of medicinal product | ||
Clofazimine | |||||
Clofibrate | |||||
Clomiphene Citrate | |||||
Clomipramine | |||||
Clomipramine Hydrochloride | |||||
Clomocycline | |||||
Clomocycline Sodium | |||||
Clonidine | |||||
Clonidine Hydrochloride | |||||
Clopamide | |||||
Clopenthixol Decanoate | |||||
Clopenthixol Hydrochloride | |||||
Clorexolone | |||||
Clotrimazole | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Cloxacillin Benzathine | |||||
Cloxacillin Sodium | |||||
Clozapine | |||||
Cocculus Indicus | |||||
Co-dergocrine Mesylate | |||||
Colaspase | |||||
Colchicine | |||||
Colestipol Hydrochloride | |||||
Colfosceril Palmitate | |||||
Colistin Sulphate | |||||
Colistin Sulphomethate | |||||
Colistin Sulphomethate Sodium | |||||
Coniine | |||||
Conium Leaf | 7.0 per cent | External | |||
Corticotrophin | |||||
Cortisone | |||||
Cortisone Acetate | |||||
Co-tetroxazine | |||||
Co-trimoxazole | |||||
Cropropamide | |||||
Crotethamide | |||||
Croton Oil | |||||
Croton Seed | |||||
Curare | |||||
Cyclofenil | |||||
Cyclopenthiazide | |||||
Cyclopentolate Hydrochloride | |||||
Cyclophosphamide | |||||
Cycloserine | |||||
Cyclosporin | |||||
Cyclothiazide | |||||
Cyproterone Acetate | |||||
Cytarabine | |||||
Cytarabine Hydrochloride | |||||
Dacarbazine | |||||
Dalteparin Sodium | |||||
Danazol | |||||
Danthron | |||||
Dantrolene Sodium | |||||
Dapsone | |||||
Dapsone Ethane Ortho Sulphonate | |||||
Daunorubicin Hydrochloride | |||||
Deanol Bitartrate | 26mg (MDD) | ||||
Debrisoquine Sulphate | |||||
Demecarium Bromide | |||||
Demeclocycline | |||||
Demeclocycline Calcium | |||||
Demeclocycline Hydrochloride | |||||
Deoxycortone Acetate | |||||
Deoxycortone Pivalate | |||||
Deptropine Citrate | |||||
Dequalinium Chloride | (1) 0.25mg | (1) Internal: throat lozenges or throat pastilles | |||
(2) 1.0 per cent | (2) External: paint | ||||
Deserpidine | |||||
Desferrioxamine Mesylate | |||||
Desflurane | |||||
Desipramine Hydrochloride | |||||
Deslanoside | |||||
Desmopressin | |||||
Desmopressin Acetate | |||||
Desogestrel | |||||
Desonide | |||||
Desoxymethasone | |||||
Dexamethasone | |||||
Dexamethasone Acetate | |||||
Dexamethasone Isonicotinate | |||||
Dexamethasone Phenylpropionate | |||||
Dexamethasone Pivalate | |||||
Dexamethasone Sodium Metasulphobenzoate | |||||
Dexamethasone Sodium Phosphate | |||||
Dexamethasone Troxundate | |||||
Dexfenfluramine Hydrochloride | |||||
Dextromethorphan Hydrobromide | Internal | (a) In the case of a prolonged release preparation: equivalent of 30mg of Dextromethorphan (MD) | |||
equivalent of 75mg of Dextromethorphan (MDD) | |||||
(b) in any other case: equivalent of 15mg of Dextromethorphan (MD) | |||||
equivalent of 75mg of Dextromethorphan (MDD) | |||||
Dextrothyroxine Sodium | |||||
Diazoxide | |||||
Dibenzepin Hydrochloride | |||||
Dichloralphenazone | |||||
Dichlorphenamide | |||||
Diclofenac Diethylammonium | 1.16 per cent | External | For maximum period of 7 days | Container or package containing not more than 30g of medicinal product | |
For local symptomatic relief of pain and inflammation in trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism | |||||
For use in adults and children not less than 12 years | |||||
Diclofenac Potassium | |||||
Diclofenac Sodium | |||||
Dicyclomine Hydrochloride | 10mg (MD) | ||||
60mg (MDD) | |||||
F49Didanosine | |||||
Dienoestrol | |||||
Diethanolamine Fusidate | |||||
Diflucortolone Valerate | |||||
Diflunisal | |||||
Digitalin | |||||
Digitalis Leaf | |||||
Digitalis Prepared | |||||
Digitoxin | |||||
Digoxin | |||||
Dihydralazine Sulphate | |||||
Dihydroergotamine Mesylate | |||||
Dihydrostreptomycin | |||||
Dihydrostreptomycin Sulphate | |||||
Diloxanide Furoate | |||||
Diltiazem Hydrochloride | |||||
Dimercaprol | |||||
Dimethisoquin Hydrochloride | Non-ophthalmic use | ||||
Dimethisterone | |||||
Dimethothiazine Mesylate | |||||
Dimethyl Sulphoxide | |||||
Dimethyltubocurarine Bromide | |||||
Dimethyltubocurarine Chloride | |||||
Dimethyltubocurarine Iodide | |||||
Dinoprost | |||||
Dinoprost Trometamol | |||||
Dinoprostone | |||||
F34Diphenhydramine Hydrochloride | All preparations except liquid-filled capsules | ||||
F87Diphenoxylate Hydrochloride | F872.5 mg | F87In combination with Atropine Sulphate for short term use as an adjunctive therapy to appropriate rehydration in acute diarrhoea | F8725 mg (MDD) | F87Container or package containing not more than 20 tablets | |
For use in persons aged 16 years and over | |||||
Tablets | |||||
Dipivefrin Hydrochloride | |||||
Dipyridamole | |||||
Disodium Etidronate | |||||
Disodium Pamidronate | |||||
Disopyramide | |||||
Disopyramide Phosphate | |||||
Distigmine Bromide | |||||
Disulfiram | |||||
Dithranol | 1.0 per cent | ||||
Dobutamine Hydrochloride | |||||
F87Dolasetron Mesilate | |||||
Domperidone | F54For the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn | F5410mg of Domperidone (MD) | F54Container or package containing not more than 200mg of Domperidone | ||
F5440mg of Domperidone (MDD) | |||||
Domperidone Maleate | F11For the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn, | F2510 mg of Domperidone as Domperidone Maleate (MD) | F11Container or package containing not more than F55200mg of Domperidone as Domperidone Maleate; | ||
F2540 mg of Domperidone as Domperidone Maleate (MDD) | |||||
F77Donepezil Hydrochloride | |||||
Dopamine Hydrochloride | |||||
Dopexamine Hydrochloride | |||||
F46Dorzolamide Hydrochloride | |||||
Dothiepin | |||||
Dothiepin Hydrochloride | |||||
Doxapram Hydrochloride | |||||
Doxazosin Mesylate | |||||
Doxepin Hydrochloride | |||||
Doxorubicin | |||||
Doxorubicin Hydrochloride | |||||
Doxycycline | |||||
Doxycycline Calcium Chelate | |||||
Doxycycline Hydrochloride | |||||
Droperidol | |||||
Dydrogesterone | |||||
Dyflos | |||||
Econazole | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Econazole Nitrate | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Ecothiopate Iodide | |||||
Edrophonium Chloride | |||||
Eflornithine Hydrochloride | |||||
F49Eformoterol Fumarate | |||||
Embutramide | |||||
Emepronium Bromide | |||||
Emetine | 1.0 per cent | ||||
Emetine Bismuth Iodide | |||||
Emetine Hydrochloride | Equivalent of 1.0 per cent of Emetine | ||||
Enalapril Maleate | |||||
Encephalitis Virus, Tick-borne, Cent Eur | |||||
Enoxacin | |||||
Enoxaparin Sodium | |||||
Enoximone | |||||
Ephedrine | (1) Internal (other than nasal sprays or nasal drops) | (1) 30mg (MD) | |||
60mg (MDD) | |||||
(2) 2.0 per cent | (2) Nasal sprays or nasal drops | ||||
(3) External | |||||
Ephedrine Hydrochloride | (1) Internal (other than nasal sprays or nasal drops) | (1) Equivalent of 30mg of Ephedrine (MD) | |||
Equivalent of 60mg of Ephedrine (MDD) | |||||
(2) Equivalent of 2.0 per cent of Ephedrine | (2) Nasal sprays or nasal drops | ||||
(3) External | |||||
Ephedrine Sulphate | (1) Internal (other than nasal sprays or nasal drops) | (1) Equivalent of 30mg of Ephedrine (MD) | |||
Equivalent of 60mg of Ephedrine (MDD) | |||||
(2) Equivalent of 2.0 per cent of Ephedrine | (2) Nasal sprays or nasal drops | ||||
(3) External | |||||
Epicillin | |||||
Epirubicin | |||||
Epirubicin Hydrochloride | |||||
Epithiazide | |||||
Epoetin Alfa | |||||
Epoetin Beta | |||||
Epoprostenol Sodium | |||||
Ergometrine Maleate | |||||
Ergometrine Tartrate | |||||
Ergot, Prepared | |||||
Ergotamine Tartrate | |||||
Erythromycin | |||||
Erythromycin Estolate | |||||
Erythromycin Ethylcarbonate | |||||
Erythromycin Ethyl Succinate | |||||
Erythromycin Lactobionate | |||||
Erythromycin Phosphate | |||||
Erythromycin Stearate | |||||
Erythromycin Thiocyanate | |||||
Esmolol Hydrochloride | |||||
Estramustine Phosphate | |||||
F7Estramustine Sodium Phosphate | |||||
Etafedrine Hydrochloride | |||||
Ethacrynic Acid | |||||
Ethambutol Hydrochloride | |||||
Ethamivan | |||||
Ethamsylate | |||||
Ethiazide | |||||
Ethinyl Androstenediol | |||||
Ethinyloestradiol | |||||
Ethionamide | |||||
Ethisterone | |||||
Ethoglucid | |||||
Ethoheptazine Citrate | |||||
Ethopropazine Hydrochloride | |||||
Ethosuximide | |||||
Ethotoin | |||||
Ethyl Biscoumacetate | |||||
Ethynodiol Diacetate | |||||
Etodolac | |||||
Etomidate | |||||
Etomidate Hydrochloride | |||||
Etoposide | |||||
Etretinate | |||||
F46Exemestane | |||||
Famciclovir | |||||
Famotidine | For the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity, and prevention of these symptoms when associated with food and drink, including nocturnal symptoms | 10mg (MD) | |||
20mg (MDD) | |||||
For maximum period of 14 days | |||||
Fazadinium Bromide | |||||
Felbinac | 3.17 per cent | External | For maximum period of 7 days | Container or package containing not more than F4450g of medicinal product | |
F26For the relief of rheumatic pain, pain of non-serious arthritic conditions and soft tissue injuries such as sprains, strains and contusions | |||||
For use in adults and children not less than 12 years | |||||
Felodipine | |||||
Felypressin | |||||
Fenbufen | |||||
Fenclofenac | |||||
Fenfluramine Hydrochloride | |||||
Fenofibrate | |||||
Fenoprofen | |||||
Fenoprofen Calcium | |||||
Fenoterol Hydrobromide | |||||
Fenticonazole Nitrate | F76External use (but in the case of vaginal use, only for the treatment of vaginal candidiasis) | ||||
Feprazone | |||||
Ferrous Arsenate | |||||
F46Ferumoxsil | |||||
F77Fexofenadine Hydrochloride | |||||
Filgrastim | |||||
Finasteride | |||||
Flavoxate Hydrochloride | |||||
Flecainide Acetate | |||||
Flosequinan | |||||
Fluanisone | |||||
Flubendazole | |||||
Fluclorolone Acetonide | |||||
Flucloxacillin Magnesium | |||||
Flucloxacillin Sodium | |||||
Fluconazole | For oral administration for the treatment of vaginal candidiasis F70or associated candidal balanitis in persons aged not less than 16 but less than 60 years | 150mg (MD) | Container or package containing not more than 150mg of Fluconazole | ||
Flucytosine | |||||
Fludrocortisone Acetate | |||||
Flufenamic Acid | |||||
Flumazenil | |||||
Flumethasone | |||||
Flumethasone Pivalate | |||||
Flunisolide | 0.025 per cent | (a) For the prevention and treatment of seasonal allergic rhinitis, including hay fever | (a) 50mcg per nostril (MD) | (a) Container or package containing not more than 6,000mcg of Flunisolide | |
100mcg per nostril (MDD) | |||||
F27For use in persons aged 18 years and over | F28For a maximum period of 3 months | ||||
In the form of a non-pressurised nasal spray | |||||
F29... | F29... | F29... | |||
F29. . . | |||||
F29. . . | |||||
F29. . . | |||||
Fluocinolone Acetonide | |||||
Fluocinonide | |||||
Fluocortin Butyl | |||||
Fluocortolone | |||||
Fluocortolone Hexanoate | |||||
Fluocortolone Pivalate | |||||
Fluorescein Dilaurate | |||||
Fluorometholone | |||||
Fluorouracil | |||||
Fluorouracil Trometamol | |||||
Fluoxetine Hydrochloride | |||||
Flupenthixol Decanoate | |||||
Flupenthixol Hydrochloride | |||||
Fluperolone Acetate | |||||
Fluphenazine Decanoate | |||||
Fluphenazine Enanthate | |||||
Fluphenazine Hydrochloride | |||||
Fluprednidene Acetate | |||||
Fluprednisolone | |||||
Fluprostenol Sodium | |||||
Flurandrenolone | |||||
Flurbiprofen | F798.75 mg | F80Throat lozenges | F8143.75 mg (MDD) | F82Container or package containing not more than 140 mg of Flurbiprofen | |
Flurbiprofen Sodium | |||||
Fluspirilene | |||||
Flutamide | |||||
Fluticasone Propionate | |||||
F77Flutrimazole | |||||
Fluvastatin Sodium | |||||
Fluvoxamine Maleate | |||||
Folic Acic | 500mcg (MDD) | ||||
Formestane | |||||
Formocortal | |||||
Foscarnet Sodium | |||||
Fosfestrol Sodium | |||||
Fosfomycin Trometamol | |||||
Fosinopril Sodium | |||||
Framycetin Sulphate | |||||
Frusemide | |||||
Furazolidone | |||||
Fusafungine | |||||
Fusidic Acid | |||||
Gabapentin | |||||
Gadoteridol | |||||
Gallamine Triethiodide | |||||
Ganciclovir | |||||
Ganciclovir Sodium | |||||
Gelsemine | 0.1 per cent | ||||
Gelsemium | 25mg (MD) | ||||
75mg (MDD) | |||||
Gemeprost | |||||
Gemfibrozil | |||||
Gentamicin | |||||
Gentamicin Sulphate | |||||
Gestodene | |||||
Gestrinone | |||||
Gestronol | |||||
Gestronol Hexanoate | |||||
Glibenclamide | |||||
Glibornuride | |||||
Gliclazide | |||||
Glipizide | |||||
Gliquidone | |||||
Glisoxepide | |||||
Glucagon | |||||
Glycopyrronium Bromide | 1mg (MD) | ||||
2mg (MDD) | |||||
Glymidine | |||||
Gonadorelin | |||||
Goserelin Acetate | |||||
Gramicidin | 0.2 per cent | External | |||
Granisetron Hydrochloride | |||||
Griseofulvin | |||||
Growth Hormone | |||||
Guanethidine Monosulphate | |||||
Guanfacine Hydrochloride | |||||
Guanoclor Sulphate | |||||
Guanoxan Sulphate | |||||
Halcinonide | |||||
Halofantrine Hydrochloride | |||||
Haloperidol | |||||
Haloperidol Decanoate | |||||
Heparin | External | ||||
Heparin Calcium | External | ||||
Heparin Sodium | |||||
Hexachlorophane | External | ||||
(a) 2.0 per cent | (a) Soaps | ||||
(b) 0.1 per cent | (b) Aerosols | ||||
(c) 0.75 per cent | (c) preparations other than soaps and aerosols | ||||
Hexamine Phenylcinchoninate | |||||
Hexobarbitone | |||||
Hexobarbitone Sodium | |||||
Hexoestrol | |||||
Hexoestrol Dipropionate | |||||
L-Histidine Hydrochloride | Dietary supplementation | ||||
Homatropine | (1) Internal | (1) 0.15mg (MD) | |||
0.45mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Homatropine Hydrobromide | 0.2mg (MD) | ||||
0.6mg (MDD) | |||||
Homatropine Methylbromide | 2mg (MD) | ||||
6mg (MDD) | |||||
Hydralazine Hydrochloride | |||||
Hydrargaphen | Local application to skin | ||||
Hydrobromic Acid | |||||
Hydrochlorothiazide | |||||
Hydrocortisone |
|
|
| ||
|
|
| |||
Hydrocortisone Acetate | Equivalent to 1.0 per cent Hydrocortisone | External | |||
For use in irritant dermatitis, contact allergic dermatitis, insect bite reactions, mild to moderate eczema, and in combination with one or more of the following: Benzyl Benzoate, Bismuth Oxide, Bismuth Subgallate, Peru Balsam, Pramoxine Hydrochloride, Zinc Oxide, for haemorrhoids F71or in combination with Miconazole Nitrate, for athlete’s foot and candidal intertrigo | Container or package containing not more than 15g of medicinal product | ||||
In the case of suppositories, container or package containing no more than 12 | |||||
For use in adults and children not less than 10 years | |||||
Cream, ointment or suppositories | |||||
Hydrocortisone Butyrate | |||||
Hydrocortisone Caprylate | |||||
Hydrocortisone Hydrogen Succinate | |||||
Hydrocortisone Sodium Phosphate | |||||
Hydrocortisone Sodium Succinate | Equivalent to 2.5mg Hydrocortisone | External | Container or package containing not more than equivalent to 50mg of Hydrocortisone | ||
For aphthous ulceration of the mouth for adults and children not less than 12 years | |||||
In the form of pellets | |||||
F34Hydrocyanic Acid | |||||
Hydroflumethiazide | |||||
Hydroxychloroquine Sulphate | Prophylaxis of malaria | ||||
Hydroxyprogesterone | |||||
Hydroxyprogesterone Enanthate | |||||
Hydroxyprogesterone Hexanoate | |||||
Hydroxyurea | |||||
Hydroxyzine Embonate | |||||
Hydroxyzine Hydrochloride | (a) For the management of pruritis associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in adults and in children not less than 12 years | (a) 25mg (MD) | (a) Container or package containing not more than 750mg of Hydroxyzine Hydrochloride | ||
75mg (MDD) | |||||
(b) For the management of pruritis associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in children not less than 6 years but less than 12 years | (b) 25 mg (MD) | (b) Container or package containing not more than 750mg of Hydroxyzine Hydrochloride | |||
50mg (MDD) | |||||
Hyoscine | (1) 0.15 per cent | (1) Internal | |||
(2) External (except ophthalmic) | |||||
Hyoscine Butylbromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 20mg (MD) | (b) Container or package containing not more than 240mg of Hyoscine Butylbromide | |||
80mg (MDD) | |||||
(2) External | |||||
Hyoscine Hydrobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 300mcg (MD) | ||||
900mcg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Hyoscine Methobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 2.5mg (MD) | ||||
7.5mg (MDD) | |||||
(2) External | |||||
Hyoscine Methonitrate | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 2.5mg (MD) | ||||
7.5mg (MDD) | |||||
(2) External | |||||
Hyoscyamine | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 300mcg (MD) | ||||
1mg (MDD) | |||||
(2) External | |||||
Hyoscyamine Hydrobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) Equivalent of 300mcg of Hyoscyamine (MD) | ||||
Equivalent of 1mg of Hyoscyamine (MDD) | |||||
(2) External | |||||
Hyoscyamine Sulphate | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) Equivalent of 300mcg of Hyoscyamine (MD) | ||||
Equivalent of 1mg of Hyoscyamine (MDD) | |||||
(2) External | |||||
Ibuprofen | Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | ||||
(1) Internal | (1)(a) In the case of a prolonged release preparation 600mg (MD) | ||||
1,200mg (MDD) | |||||
(b) in any other case 400mg (MD) | |||||
1,200mg (MDD) | |||||
(2) 5.0 per cent | (2) External | ||||
F47(3) 10.0 per cent | F47(3) External | F47(3) 125 mg (MD) 500 mg (MDD) | F47(3) Container or package containing not more than F5650g of medicinal product | ||
F34Ibuprofen Lysine | Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | (a) in the case of a prolonged release preparation 600 mg (MD) 1,200 mg (MDD) | |||
Internal | (b) in any other case 400 mg (MD) 1,200 mg (MDD) | ||||
Idarubicin Hydrochloride | |||||
Idoxuridine | |||||
Ifosfamide | |||||
Ignatius Bean | |||||
F49Imidapril Hydrochloride | |||||
Imipenem Hydrochloride | |||||
Imipramine | |||||
Imipramine Hydrochloride | |||||
Imipramine Ion Exchange Resin Bound Salt or Complex | |||||
F64Indapamide | |||||
Indapamide Hemihydrate | |||||
Indomethacin | |||||
Indomethacin Sodium | |||||
Indoprofen | |||||
Indoramin Hydrochloride | |||||
Inosine Pranobex | |||||
F18Insulin | |||||
Iodamide | |||||
Iodamide Meglumine | |||||
Iodamide Sodium | |||||
Iohexol | |||||
Iomeprol | |||||
Iopamidol | |||||
Iopentol | |||||
Iothalamic Acid | |||||
Ioversol | |||||
Ioxaglic Acid | |||||
Ipratropium Bromide | |||||
Iprindole Hydrochloride | |||||
Iproniazid Phosphate | |||||
F77Irbesartan | |||||
Isoaminile | |||||
Isoaminile Citrate | |||||
Isocarboxazid | |||||
Isoconazole Nitrate | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Isoetharine | |||||
Isoetharine Hydrochloride | |||||
Isoetharine Mesylate | |||||
Isoniazid | |||||
Isoprenaline Hydrochloride | |||||
Isoprenaline Sulphate | |||||
Isopropamide Iodide | Equivalent of 2.5mg of Isopropamide ion (MD) | ||||
Equivalent of 5.0mg of Isopropamide ion (MDD) | |||||
Isotretinoin | |||||
Isradipine | |||||
Itraconazole | |||||
Jaborandi | External | ||||
Kanamycin Acid Sulphate | |||||
Kanamycin Sulphate | |||||
Ketamine Hydrochloride | |||||
Ketoconazole | 2.0 per cent | F31(a) Maximum frequency of application of once every 3 days | F31(a) Container or package containing not more than 120ml of medicinal product and containing not more than 2,400mg of Ketoconazole | ||
For the prevention and treatment of dandruff and seborrhoeic dermatitis of the scalp | |||||
In the form of a shampoo | |||||
F32(b) For the treatment of the following mycotic infections of the skin: tinea pedis, tinea cruris and candidal intertrigo | |||||
Ketoprofen | 2.5 per cent | External | For maximum period of 7 days | Container or package containing not more than 30g of medicinal product | |
For rheumatic and muscular pain in adults and children not less than 12 | |||||
Ketorolac Trometamol | |||||
Ketotifen Fumarate | |||||
Labetalol Hydrocholoride | |||||
Lachesine Chloride | |||||
Lacidipine | |||||
Lamotrigine | |||||
Lanatoside C | |||||
Lanatoside Complex A, B and C | |||||
F64Lansoprazole | |||||
Latamoxef Disodium | |||||
F64Lercanidipine Hydrochloride | |||||
Levallorphan Tartrate | |||||
Levobunolol Hydrochloride | |||||
F34Levocabastine Hydrochloride | Equivalent of 0.05 per cent Levocabastine | (1) Nasal sprays | (1) Container or package containing not more than 10 ml of medicinal product | ||
For the symptomatic treatment of seasonal allergic rhinitis | |||||
(2) Aqueous eye drops | (2) Container or package containing not more than 4 ml of medicinal product | ||||
For the symptomatic treatment of seasonal allergic conjunctivitis | |||||
F45Levocarnitine | F45For dietary supplementation | ||||
Levodopa | |||||
F77Levofloxacin | |||||
Levonorgestrel | F680.75mg | F68for use as an emergency contraceptive in women aged 16 years and over | |||
Lidoflazine | |||||
Lignocaine | Non-ophthalmic use | ||||
Lignocaine Hydrochloride | Non-ophthalmic use | ||||
Lincomycin | |||||
Lincomycin Hydrochloride | |||||
Liothyronine Sodium | |||||
Lisinopril | |||||
Lithium Carbonate | Equivalent of 5mg of Lithium (MD) | ||||
Equivalent of 15mg of Lithium (MDD) | |||||
Lithium Citrate | |||||
Lithium Succinate | |||||
Lithium Sulphate | Equivalent of 5mg of Lithium (MD) | ||||
Equivalent of 15mg of Lithium (MDD) | |||||
Lobeline | (1) Internal | (1) 3mg (MD) | |||
9mg (MDD) | |||||
(2) External | |||||
Lobeline Hydrochloride | (1) Internal | (1) Equivalent of 3mg of Lobeline (MD) | |||
Equivalent of 9mg of Lobeline (MDD) | |||||
(2) External | |||||
Lobeline Sulphate | (1) Internal | (1) Equivalent of 3mg of Lobeline (MD) | |||
Equivalent of 9mg of Lobeline (MDD) | |||||
(2) External | |||||
Lodoxamide Trometamol | F57equivalent of 0.1 per cent Lodoxamide | F58For the treatment of ocular signs and symptoms of allergic conjunctivitis, in adults and in children aged 4 years and over | |||
Lofepramine | |||||
Lofepramine Hydrochloride | |||||
Lofexidine Hydrochloride | |||||
Lomefloxacin Hydrochloride | |||||
Lomustine | |||||
Loperamide Hydrochloride | Treatment of acute diarrhoea | ||||
Loratidine | 10mg (MDD) | F83. . . | |||
F43Lornoxicam | |||||
F43Losartan Potassium | |||||
Loxapine Succinate | |||||
Lung Surfactant Porcine | |||||
Luteinising Hormone | |||||
Lymecycline | |||||
Lynoestrenol | |||||
Lypressin | |||||
Lysuride Maleate | |||||
Mafenide | |||||
Mafenide Acetate | |||||
Mafenide Hydrochloride | |||||
Mafenide Propionate | 5.0 per cent | Eye drops | |||
Magnesium Fluoride | |||||
Magnesium Metrizoate | |||||
Mandragora Autumnalis | |||||
Mannomustine Hydrochloride | |||||
Maprotiline Hydrochloride | |||||
Mebanazine | |||||
Mebendazole | For oral use in the treatment of enterobiasis in adults and in children not less than 2 years | 100mg (MD) | Container or package containing not more than 800mg of Mebendazole | ||
Mebeverine Hydrochloride |
|
| |||
|
| ||||
Mebeverine Pamoate | |||||
Mebhydrolin | |||||
Mebhydrolin Napadisylate | |||||
Mecamylamine Hydrochloride | |||||
Mecillinam | |||||
Meclofenoxate Hydrochloride | |||||
Medigoxin | |||||
Medrogestone | |||||
Medroxyprogesterone Acetate | |||||
Mefenamic Acid | |||||
Mefloquine Hydrochloride | |||||
Mefruside | |||||
Megestrol | |||||
Megestrol Acetate | |||||
Meglumine Gadopentetate | |||||
Meglumine Iodoxamate | |||||
Meglumine Ioglycamate | |||||
Meglumine Iothalamate | |||||
Meglumine Iotroxate | |||||
Meglumine Ioxaglate | |||||
F64Meloxicam | |||||
Melphalan | |||||
Melphalan Hydrochloride | |||||
Menotrophin | |||||
Mepenzolate Bromide | 25mg (MD) | ||||
75mg (MDD) | |||||
Mephenesin | |||||
Mephenesin Carbamate | |||||
Mepivacaine Hydrochloride | Any use except ophthalmic use | ||||
Meptazinol Hydrochloride | |||||
Mequitazine | |||||
F77Mercaptamine Bitartrate | |||||
Mercaptopurine | |||||
Mersalyl | |||||
Mersalyl Acid | |||||
Mesalazine | |||||
Mesna | |||||
Mestranol | |||||
Metaraminol Tartrate | |||||
Metergoline | |||||
Metformin Hydrochloride | |||||
Methacycline | |||||
Methacycline Calcium | |||||
Methacycline Hydrochloride | |||||
Methallenoestril | |||||
Methicillin Sodium | |||||
Methixene | |||||
Methixene Hydrochloride | |||||
Methocarbamol | |||||
Methocidin | Throat lozenges and throat pastilles | ||||
Methohexitone Sodium | |||||
Methoin | |||||
Methoserpidine | |||||
Methotrexate | |||||
Methotrexate Sodium | |||||
Methotrimeprazine | |||||
Methotrimeprazine Hydrochloride | |||||
Methotrimeprazine Maleate | |||||
Methoxamine Hydrochloride | 0.25 per cent | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle | |||
Methsuximide | |||||
Methyclothiazide | |||||
Methyldopa | |||||
Methyldopate Hydrochloride | |||||
Methylephedrine Hydrochloride | 30mg (MD) | ||||
60mg (MDD) | |||||
Methylprednisolone | |||||
Methylprednisolone Acetate | |||||
Methylprednisolone Sodium Succinate | |||||
Methylthiouracil | |||||
Methysergide Maleate | |||||
Metipranolol | |||||
Metirosine | |||||
Metoclopramide Hydrochloride | |||||
Metolazone | |||||
Metoprolol Fumarate | |||||
Metoprolol Succinate | |||||
Metoprolol Tartrate | |||||
Metronidazole | |||||
Metronidazole Benzoate | |||||
Metyrapone | |||||
Mexiletine Hydrochloride | |||||
Mezlocillin Sodium | |||||
Mianserin Hydrochloride | |||||
Miconazole | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Miconazole Nitrate | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Mifepristone | |||||
Miglitol | |||||
Milrinone | |||||
Milrinone Lactate | |||||
Minocycline | |||||
Minocycline Hydrochloride | |||||
Minoxidil | F12(1) 2.0 per cent | F12(1) External | |||
F12(2) 5.0 per cent | (2) External use for the treatment of alopecia androgenetica, in men aged 18 to 65 (but not in women); | ||||
F49Mirtazapine | |||||
Misoprostol | |||||
Mitobronitol | |||||
Mitomycin | |||||
Mitozantrone Hydrochloride | |||||
Mivacurium Chloride | |||||
F7Mizolastine | |||||
Moclobemide | |||||
F77Modafinil | |||||
F46Moexipril Hydrochloride | |||||
Molgramostim | |||||
Molindone Hydrochloride | |||||
Mometasone Furoate | |||||
Moracizine Hydrochloride | |||||
Morazone Hydrochloride | |||||
F49Moxonidine | |||||
Mupirocin | |||||
Mupirocin Calcium | |||||
Mustine Hydrochloride | |||||
Nabilone | |||||
Nabumetone | |||||
Nadolol | |||||
Nafarelin Acetate | |||||
Naftidrofuryl Oxalate | |||||
Naftifine Hydrochloride | |||||
Nalbuphine Hydrochloride | |||||
Nalidixic Acid | |||||
Nalorphine Hydrobromide | |||||
Naloxone Hydrochloride | |||||
Naltrexone Hydrochloride | |||||
Naphazoline Hydrochloride | (1) 0.05 per cent | (1) Nasal sprays or nasal drops not containing liquid paraffin as a vehicle | |||
(2) 0.015 per cent | (2) Eye drops | ||||
Naphazoline Nitrate | 0.05 per cent | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle | |||
Naproxen | |||||
Naproxen Sodium | |||||
F77Naratriptan Hydrochloride | |||||
Natamycin | |||||
F43Nebivolol Hydrochloride | |||||
Nedocromil Sodium | F332.0 per cent | F33For the prevention, relief and treatment of seasonal and perennial allergic conjunctivitis | F33Container or package containing not more than 3 ml of medicinal product | ||
Nefazodone Hydrochloride | |||||
Nefopam Hydrochloride | |||||
Neomycin | |||||
Neomycin Oleate | |||||
Neomycin Palmitate | |||||
Neomycin Sulphate | |||||
Neomycin Undecanoate | |||||
Neostigmine Bromide | |||||
Neostigmine Methylsulphate | |||||
Netilmicin Sulphate | |||||
Nicardipine Hydrochloride | |||||
Nicergoline | |||||
F7Niceritrol | |||||
Nicotinic Acid | Any use, except for the treatment of hyperlipidaemia | 600mg (MDD) | |||
Nicoumalone | |||||
Nifedipine | |||||
Nifenazone | |||||
Nikethamide | |||||
F34Nilutamide | |||||
Nimodipine | |||||
Niridazole | |||||
F43Nisoldipine | |||||
Nitrendipine | |||||
Nitrofurantoin | |||||
Nitrofurazone | |||||
Nizatidine | For the prevention F13and treatment of the symptoms of food-related heartburn F13and meal-induced indigestion | 75mg (MD) | |||
F14150mg (MDD) | |||||
F15For a maximum period of 14 days | |||||
For use in adults and children not less than 16 years | |||||
Nomifensine Maleate | |||||
Noradrenaline | |||||
Noradrenaline Acid Tartrate | |||||
Norethisterone | |||||
Norethisterone Acetate | |||||
Norethisterone Enanthate | |||||
Norethynodrel | |||||
Norfloxacin | |||||
Norgestimate | |||||
Norgestrel | |||||
Nortriptyline Hydrochloride | |||||
Noscapine | |||||
Noscapine Hydrochloride | |||||
Novobiocin Calcium | |||||
Novobiocin Sodium | |||||
Nux Vomica Seed | |||||
Nystatin | F423.0 per cent | F42External | F42Container or package containing not more than 15g of medicinal product | ||
For use in combination with Hydrocortisone of maximum strength 0.5 per cent for intertrigo | |||||
For use in adults and children not less than 10 years | |||||
Octacosactrin | |||||
Octreotide | |||||
Oestradiol | |||||
Oestradiol Benzoate | |||||
Oestradiol Cypionate | |||||
Oestradiol Dipropionate | |||||
Oestradiol Diundecanoate | |||||
Oestradiol Enanthate | |||||
Oestradiol Phenylpropionate | |||||
Oestradiol Undecanoate | |||||
Oestradiol Valerate | |||||
Oestriol | |||||
Oestriol Succinate | |||||
Oestrogenic Substances Conjugated | |||||
Oestrone | |||||
Ofloxacin | |||||
Olsalazine Sodium | |||||
Omeprazole | |||||
F49Omeprazole Magnesium | |||||
Ondansetron Hydrochloride | |||||
Orciprenaline Sulphate | |||||
Orphenadrine Citrate | |||||
Orphenadrine Hydrochloride | |||||
Ouabain | |||||
Ovarian Gland Dried | |||||
Oxamniquine | |||||
Oxantel Embonate | |||||
Oxaprozin | |||||
Oxatomide | |||||
Oxedrine Tartrate | |||||
Oxethazaine | 10mg (MD) | Container or package containing not more than 400mg of Oxethazaine | |||
30mg (MDD) | |||||
Oxitropium Bromide | |||||
Oxolinic Acid | |||||
Oxpentifylline | |||||
Oxprenolol Hydrochloride | |||||
Oxybuprocaine Hydrochloride | Non-ophthalmic use | ||||
Oxybutynin Hydrochloride | |||||
Oxypertine | |||||
Oxypertine Hydrochloride | |||||
Oxyphenbutazone | |||||
Oxyphencyclimine Hydrochloride | |||||
Oxyphenonium Bromide | 5mg (MD) | ||||
15mg (MDD) | |||||
Oxytetracycline | |||||
Oxytetracycline Calcium | |||||
Oxytetracycline Dihydrate | |||||
Oxytetracycline Hydrochloride | |||||
Oxytocin, natural | |||||
Oxytocin, synthetic | |||||
Pancreatin | (1) 21,000 European Pharmacopoeia units of lipase per capsule | (1) capsules | |||
(2) 25,000 European Pharmacopoeia units of lipase per gram | (2) powder | ||||
Pancuronium Bromide | |||||
F64Pantoprazole Sodium | |||||
Papaverine | (1) By inhaler | ||||
(2) Otherwise than by inhaler | (2) 50mg (MD) | ||||
150mg (MDD) | |||||
Papaverine Hydrochloride | (1) By inhaler | ||||
(2) Otherwise than by inhaler | (2) Equivalent of 50mg of Papaverine (MD) | ||||
Equivalent of 150mg of Papaverine (MDD) | |||||
F19Paracetamol |
|
|
| ||
|
| ||||
|
| ||||
Paraldehyde | |||||
Paramethadione | |||||
Paramethasone Acetate | |||||
Parathyroid Gland | |||||
Pargyline Hydrochloride | |||||
Paroxetine Hydrochloride | |||||
Pecilocin | |||||
Penamecillin | |||||
Penbutolol Sulphate | |||||
F64Penciclovir | |||||
Penicillamine | |||||
Penicillamine Hydrochloride | |||||
Pentamidine Isethionate | |||||
Penthienate Bromide | 5mg (MD) | ||||
15mg (MDD) | |||||
Pentolinium Tartrate | |||||
Perfluamine | |||||
Pergolide Mesylate | |||||
Perhexiline Maleate | |||||
Pericyazine | |||||
Perindopril | |||||
Perindopril Erbumine | |||||
Perphenazine | |||||
Phenacetin | 0.1 per cent | ||||
Phenazone | External | ||||
Phenazone Salicylate | |||||
Phenbutrazate Hydrochloride | |||||
Phenelzine Sulphate | |||||
Phenethicillin Potassium | |||||
Phenformin Hydrochloride | |||||
Phenglutarimide Hydrochloride | |||||
Phenindione | |||||
F20Phenolphthalein. | |||||
Phenoxybenzamine Hydrochloride | |||||
Phenoxymethylpenicillin | |||||
Phenoxymethylpenicillin Calcium | |||||
Phenoxymethylpenicillin Potassium | |||||
Phenprocoumon | |||||
Phensuximide | |||||
Phentolamine Hydrochloride | |||||
Phentolamine Mesylate | |||||
Phenylbutazone | |||||
Phenylbutazone Sodium | |||||
Phenylpropanolamine Hydrochloride | Internal | ||||
(1) all preparations except prolonged release capsules, nasal sprays and nasal drops | (1) 25mg (MD) | ||||
100mg (MDD) | |||||
(2) prolonged release capsules | (2) 50mg (MD) | ||||
100mg (MDD) | |||||
(3) 2.0 per cent | (3) nasal sprays and nasal drops | ||||
Phenytoin | |||||
Phenytoin Sodium | |||||
Phthalylsulphathiazole | |||||
Physostigmine | |||||
Physostigmine Aminoxide Salicylate | |||||
Physostigmine Salicylate | |||||
Physostigmine Sulphate | |||||
F34Phytomenadione | Any use except the prevention or treatment of haemorrhagic disorders | ||||
Picrotoxin | |||||
Pilocarpine | |||||
Pilocarpine Hydrochloride | |||||
Pilocarpine Nitrate | |||||
Pimozide | |||||
Pindolol | |||||
Pipenzolate Bromide | 5mg (MD) | ||||
15mg (MDD) | |||||
Piperacillin Sodium | |||||
Piperazine Oestrone Sulphate | |||||
Piperidolate Hydrochloride | 50mg (MD) | ||||
150mg (MDD) | |||||
Pipothiazine Palmitate | |||||
Piracetam | |||||
Pirbuterol Acetate | |||||
Pirbuterol Hydrochloride | |||||
F16Pirenzepine Dihydrochloride Monohydrate | |||||
Pirenzepine Hydrochloride | |||||
Piretanide | |||||
Piroxicam | 0.5 per cent | External | For maximum period of 7 days | Container or package containing not more than 30g of medicinal product | |
For the relief of rheumatic pain, pain of non-serious arthritic conditions and muscular aches, pains and swellings such as strains, sprains and sports injuries | |||||
For use in adults and children not less than 12 years | |||||
F7Piroxicam Beta-cyclodextrin | |||||
Pituitary Gland (Whole Dried) | By inhaler | ||||
Pituitary Powdered (Posterior Lobe) | By inhaler | ||||
Pivampicillin | |||||
Pivampicillin Hydrochloride | |||||
Pivmecillinam | |||||
Pivmecillinam Hydrochloride | |||||
Pizotifen | |||||
Pizotifen Malate | |||||
Plicamycin | |||||
Podophyllotoxin | |||||
Podophyllum | |||||
Podophyllum Indian | |||||
Podophyllum Resin | 20.0 per cent | External | |||
Ointment or impregnated plaster | |||||
Poldine Methylsulphate | 2mg (MD) | ||||
6mg (MDD) | |||||
Polidexide | |||||
Polyestradiol Phosphate | |||||
Polymyxin B Sulphate | |||||
Polythiazide | |||||
Poppy Capsule | |||||
Potassium Arsenite | 0.0127 per cent | ||||
Potassium Bromide | |||||
Potassium Canrenoate | |||||
Potassium Clavulanate | |||||
Potassium Perchlorate | |||||
Practolol | |||||
Pralidoxime Chloride | |||||
Pralidoxime Iodide | |||||
Pralidoxime Mesylate | |||||
F77Pramipexole Hydrochloride | |||||
Pravastatin Sodium | |||||
Prazosin Hydrochloride | |||||
Prednisolone | |||||
Prednisolone Acetate | |||||
Prednisolone Butylacetate | |||||
Prednisolone Hexanoate | |||||
Prednisolone Metasulphobenzoate | |||||
Prednisolone Metasulphobenzoate Sodium | |||||
Prednisolone Pivalate | |||||
Prednisolone Sodium Phosphate | |||||
Prednisolone Steaglate | |||||
Prednisone | |||||
Prednisone Acetate | |||||
Prenalterol Hydrochloride | |||||
Prenylamine Lactate | |||||
Prilocaine Hydrochloride | Non-ophthalmic use | ||||
Primidone | |||||
Probenecid | |||||
Probucol | |||||
Procainamide Hydrochloride | |||||
Procaine Hydrochloride | Non-ophthalmic use | ||||
Procaine Penicillin | |||||
Procarbazine Hydrochloride | |||||
Prochlorperazine | |||||
Prochlorperazine Edisylate | |||||
Prochlorperazine Maleate | F763mg | F76Buccal tablets for the treatment of nausea and vomiting in cases of previously diagnosed migraine only. For use in persons aged 18 years and over. | F7612mg (MDD) | F76Container or package containing not more than 8 tablets | |
Prochlorperazine Mesylate | |||||
Procyclidine Hydrochloride | |||||
Progesterone | |||||
Prolactin | |||||
Proligestone | |||||
Prolintane Hydrochloride | |||||
Promazine Embonate | |||||
Promazine Hydrochloride | |||||
Propafenone | |||||
Propafenone Hydrochloride | |||||
Propanidid | |||||
Propantheline Bromide | 15mg (MD) | ||||
45mg (MDD) | |||||
F43Propiverine Hydrochloride | |||||
Propofol | |||||
Propranolol Hydrochloride | |||||
Propylthiouracil | |||||
Proquazone | |||||
Protamine Sulphate | |||||
Prothionamide | |||||
Protirelin | |||||
Protriptyline Hydrochloride | |||||
Proxymetacaine Hydrochloride | Non-ophthalmic use | ||||
Pseudoephedrine Hydrochloride | Internal | (a) In the case of a prolonged release preparation | |||
120mg (MD) | |||||
240mg (MDD) | |||||
(b) in any other case 60mg (MD) | |||||
240mg (MDD) | |||||
Pseudoephedrine Sulphate | 60mg (MD) | ||||
180mg (MDD) | |||||
Pyrantel Embonate | (a) For the treatment of enterobiosis, in adults and children not less than 12 years | (a) 750mg MDD (as a single dose) | (a) Container or package containing not more than 750mg of Pyrantel Embonate | ||
(b) For the treatment of enterobiosis, in children less than 12 years but not less than 6 years | (b) 500mg MDD (as a single dose) | (b) Container or package containing not more than 750mg of Pyrantel Embonate | |||
(c) For the treatment of enterobiosis in children less than 6 years but not less than 2 years | (c) 250mg MDD (as a single dose) | (c) Container or package containing not more than 750mg of Pyrantel Embonate | |||
Pyrantel Tartrate | |||||
Pyrazinamide | |||||
Pyridostigmine Bromide | |||||
Pyrimethamine | |||||
F43Quetiapine Fumarate | |||||
F46Quinagolide Hydrochloride | |||||
Quinapril | |||||
F16Quinapril Hydrochloride | |||||
Quinestradol | |||||
Quinestrol | |||||
Quinethazone | |||||
Quinidine | |||||
Quinidine Bisulphate | |||||
Quinidine Polygalacturonate | |||||
Quinidine Sulphate | |||||
Quinine | 100mg (MD) | ||||
300mg (MDD) | |||||
Quinine Bisulphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Cinchophen | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Dihydrochloride | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Ethyl Carbonate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Glycerophosphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Hydrobromide | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Hydrochloride | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Iodobismuthate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Phosphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Salicylate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Sulphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Tannate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine in combination with Urea Hydrochloride | |||||
Ramipril | |||||
F49Ranitidine Bismuth Citrate | |||||
Ranitidine Hydrochloride | For the short term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity F5or the prevention of these symptoms when associated with consuming food and drink | Equivalent to 75mg of Ranitidine (MD) | |||
Equivalent to 300mg of Ranitidine (MDD) | |||||
For a maximum period of 14 days | |||||
Rauwolfia Serpentina | |||||
Rauwolfia Vomitoria | |||||
Razoxane | |||||
F77Reboxetine Mesilate | |||||
Remoxipride Hydrochloride | |||||
Reproterol Hydrochloride | |||||
Rescinnamine | |||||
Reserpine | |||||
Rifabutin | |||||
Rifampicin | |||||
Rifampicin Sodium | |||||
Rifamycin | |||||
F49Rimexolone | |||||
Rimiterol Hydrobromide | |||||
Risperidone | |||||
Ritodrine Hydrochloride | |||||
Rolitetracycline Nitrate | |||||
F87Ropinirole Hydrochloride | |||||
Sabadilla | |||||
Salbutamol | |||||
Salbutamol Sulphate | |||||
Salcatonin | |||||
Salcatonin Acetate | |||||
Salmefamol | |||||
Salmeterol Xinafoate | |||||
Salsalate | |||||
Saralasin Acetate | |||||
Selegiline Hydrochloride | |||||
Semisodium Valproate | |||||
F77Sertindole | |||||
F49Sertraline Hydrochloride | |||||
Serum Gonadotrophin | |||||
F49Sevoflurane | |||||
Silver Sulphadiazine | |||||
Simvastatin | |||||
Sissomicin | |||||
Sissomicin Sulphate | |||||
Snake Venoms | |||||
Sodium Acetrizoate | |||||
Sodium Aminosalicylate | |||||
Sodium Antimonylgluconate | |||||
Sodium Arsanilate | |||||
Sodium Arsenate | |||||
Sodium Arsenite | 0.013 per cent | ||||
Sodium Bromide | |||||
Sodium Clodronate | |||||
Sodium Cromoglycate | (a) For nasal admistration | ||||
(b) 2.0 per cent | (b) For the treatment of acute seasonal allergic conjunctivitis F6or perennial allergic conjunctivitis | (b) Container or package containing not more than 10ml of medicinal product | |||
In the form of aqueous eye drops | |||||
(c) 4.0 per cent | (c) For the treatment of acute seasonal allergic conjunctivitis | (c) Container or package containing not more than 5g of medicinal product | |||
In the form of an eye ointment | |||||
Sodium Ethacrynate | |||||
Sodium Fluoride | (1) 0.33 per cent | (1) Dentifrices | |||
(2) Other preparations for use in the prevention of dental caries | |||||
In the form of | |||||
(a) tablets or drops | (a) 2.2 mg (MDD) | ||||
(b) 0.2 per cent | (b) mouth rinses other than those for daily use | ||||
(c) 0.05 per cent | (c) mouth rinses for daily use | ||||
Sodium Fusidate | |||||
Sodium Metrizoate | |||||
Sodium Monofluorophosphate | 1.14 per cent | Dentrifrice | |||
Sodium Oxidronate | |||||
Sodium Stibogluconate | |||||
Sodium Valproate | |||||
Somatorelin Acetate | |||||
Sotalol Hydrochloride | |||||
F46Sparfloxacin | |||||
Spectinomycin | |||||
Spectinomycin Hydrochloride | |||||
Spiramycin | |||||
Spiramycin Adipate | |||||
Spironolactone | |||||
Stannous Fluoride | (F721) 0.62 per cent | (F721) Dentifrice | |||
F72(2) 0.4 per | F72(2) Dental gels for use in the prevention and treatment of dental caries and decalcification of the teeth | ||||
Stilboestrol | |||||
Stilboestrol Dipropionate | |||||
Streptodornase | External | ||||
Streptokinase | External | ||||
Streptomycin | |||||
Streptomycin Sulphate | |||||
Strychnine | |||||
Strychnine Arsenate | |||||
Strychnine Hydrochloride | |||||
F34Strychnine Nitrate | |||||
Styramate | |||||
Succinylsulphathiazole | |||||
Sucralfate | |||||
Sulbactam Sodium | |||||
Sulbenicillin | |||||
Sulbenicillin Sodium | |||||
Sulconazole Nitrate | External (except vaginal) | ||||
F34Sulfabenzamide | |||||
Sulfacytine | |||||
Sulfadoxine | |||||
Sulfamerazine | |||||
Sulfamerazine Sodium | |||||
Sulfametopyrazine | |||||
Sulfamonomethoxine | |||||
Sulindac | |||||
Sulphacetamide | |||||
Sulphacetamide Sodium | |||||
Sulphadiazine | |||||
Sulphadiazine Sodium | |||||
Sulphadimethoxine | |||||
Sulphadimidine | |||||
Sulphadimidine Sodium | |||||
Sulphafurazole | |||||
Sulphafurazole Diethanolamine | |||||
Sulphaguanidine | |||||
Sulphaloxic Acid | |||||
Sulphamethizole | |||||
Sulphamethoxazole | |||||
Sulphamethoxydiazine | |||||
Sulphamethoxypyridazine | |||||
Sulphamethoxypyridazine Sodium | |||||
Sulphamoxole | |||||
Sulphanilamide | |||||
Sulphaphenazole | |||||
Sulphapyridine | |||||
Sulphapyridine Sodium | |||||
Sulphasalazine | |||||
Sulphathiazole | |||||
Sulphathiazole Sodium | |||||
Sulphaurea | |||||
Sulphinpyrazone | |||||
Sulpiride | |||||
Sultamicillin | |||||
Sultamicillin Tosylate | |||||
Sulthiame | |||||
Sumatriptan Succinate | |||||
Suprofen | |||||
Suxamethonium Bromide | |||||
Suxamethonium Chloride | |||||
Suxethonium Bromide | |||||
F43Tacalcitol Monohydrate | |||||
Tacrine Hydrochloride | |||||
Talampicillin | |||||
Talampicillin Hydrochloride | |||||
Talampicillin Napsylate | |||||
Tamoxifen | |||||
Tamoxifen Citrate | |||||
F64Tamsulosin Hydrochloride | |||||
F49Tazarotene | |||||
Tazobactam Sodium | |||||
Teicoplanin | |||||
F77Temocapril Hydrochloride | |||||
Temocillin Sodium | |||||
Tenoxicam | |||||
Terazosin Hydrochloride | |||||
Terbinafine | F841.0 per cent | F85External use for the treatment of tinea pedis, tinea cruris and tinea corporis. In the form of a gel | F86Container or package containing not more than 30 grams of medicinal product | ||
F48Terbinafine Hydrochloride | F481.0 per cent | (F741) F73Preparations, other than spray solutions, forF48external use for the treatment of tinea pedis and tinea cruris | (F741) F48Container or package containing not more than 15 g of medicinal product. | ||
F75(2) Spray solutions for external use for the treatment of tinea corporis, tinea cruris and tinea pedis | F75(2) Container containing not more than 30ml of medicinal product | ||||
Terbutaline | |||||
Terbutaline Sulphate | |||||
Terfenadine | F2. . . | F2... | |||
Terlipressin | |||||
Terodiline Hydrochloride | |||||
F77Testosterone | |||||
Tetrabenazine | |||||
Tetracosactrin | |||||
Tetracosactrin Acetate | |||||
Tetracycline | |||||
Tetracycline Hydrochloride | |||||
Tetracycline Phosphate Complex | |||||
Tetroxoprim | |||||
Thallium Acetate | |||||
Thallous Chloride | |||||
Thiabendazole | |||||
Thiambutosine | |||||
Thiethylperazine Malate | |||||
Thiethylperazine Maleate | |||||
Thiocarlide | |||||
Thioguanine | |||||
Thiopentone Sodium | |||||
Thiopropazate Hydrochloride | |||||
Thioproperazine Mesylate | |||||
Thioridazine | |||||
Thioridazine Hydrochloride | |||||
Thiosinamine | |||||
Thiotepa | |||||
Thiothixene | |||||
Thiouracil | |||||
Thymoxamine Hydrochloride | |||||
Thyroid | |||||
Thyrotrophin | |||||
Thyroxine Sodium | |||||
Tiamulin Fumarate | |||||
Tiaprofenic Acid | |||||
Tibolone | |||||
Ticarcillin Sodium | |||||
F64Ticlopidine Hydrochloride | |||||
Tigloidine Hydrobromide | |||||
F64Tiludronate Disodium | |||||
Timolol Maleate | |||||
Tinidazole | |||||
Tinzaparin | |||||
Tioconazole | (1) 2.0 per cent | (1) External (except vaginal) | |||
(2) Vaginal for treatment of vaginal candidiasis | |||||
F46Tizanidine Hydrochloride | |||||
Tobramycin | |||||
Tobramycin Sulphate | |||||
Tocainide Hydrochloride | |||||
Tofenacin Hydrochloride | |||||
Tolazamide | |||||
Tolazoline Hydrochloride | External | ||||
Tolbutamide | |||||
Tolbutamide Sodium | |||||
Tolfenamic Acid | |||||
Tolmetin Sodium | |||||
F49Topiramate | |||||
F7Torasemide | |||||
F64Toremifene | |||||
Tramadol Hydrochloride | |||||
Trandolapril | |||||
Tranexamic Acid | |||||
Tranylcypromine Sulphate | |||||
Trazodone Hydrochloride | |||||
Treosulfan | |||||
Tretinoin | |||||
Triamcinolone | |||||
Triamcinolone Acetonide | F62(1) 0.1 per cent | F62(1) For the treatment of common mouth ulcers | F62(1) Container or package containing not more than 5g of medicinal product | ||
F63(2) In the form of a non-pressurised nasal spray, for the treatment of symptoms of seasonal allergic rhinitis in persons aged 18 years and over | F63(2) 110mcg per nostril (MD) | F63Container or package containing not more than 3.575mg of Triamcinolone Acetonide | |||
110mcg per nostril (MDD) | |||||
For a maximum period of 3 months | |||||
Triamcinolone Diacetate | |||||
Triamcinolone Hexacetonide | |||||
Triamterene | |||||
Tribavirin | |||||
Triclofos Sodium | |||||
Trientine Dihydrochloride | |||||
Trifluoperazine | |||||
Trifluoperazine Hydrochloride | |||||
Trifluperidol | |||||
Trifluperidol Hydrochloride | |||||
Trilostane | |||||
Trimeprazine | |||||
Trimeprazine Tartrate | |||||
Trimetaphan Camsylate | |||||
Trimetazidine | |||||
Trimetazidine Hydrochloride | |||||
Trimethoprim | |||||
Trimipramine Maleate | |||||
Trimipramine Mesylate | |||||
Tropicamide | |||||
Tropisetron Hydrochloride | |||||
Troxidone | |||||
L-Tryptophan | (1) Oral | ||||
Dietary supplementation | |||||
(2) External | |||||
Tubocurarine Chloride | |||||
Tulobuterol | |||||
Tulobuterol Hydrochloride | |||||
Tyrothricin | Throat lozenges or throat pastilles | ||||
Uramustine | |||||
Urea Stibamine | |||||
Urethane | |||||
Uridine 5'-triphosphate | |||||
Urofollitrophin | |||||
Urokinase | |||||
Ursodeoxychoic Acid | |||||
Vaccine: Bacillus Salmonella Typhi | |||||
Vaccine: Poliomyelitis (Oral) | |||||
F46Valaciclovir Hydrochloride | |||||
Valproic Acid | |||||
F77Valsartan | |||||
Vancomycin Hydrochloride | |||||
Vasopressin | |||||
Vasopressin Tannate | |||||
Vecuronium Bromide | |||||
F46Venlafaxine Hydrochloride | |||||
Verapamil Hydrochloride | |||||
Veratrine | |||||
Veratrum, Green | |||||
Veratrum, White | |||||
Vidarabine | |||||
Vigabatrin | |||||
Viloxazine Hydrochloride | |||||
Vinblastine Sulphate | |||||
Vincristine Sulphate | |||||
Vindesine Sulphate | |||||
Viomycin Pantothenate | |||||
Viomycin Sulphate | |||||
Vitamin A | (1) Internal | (1) 7,500iu (2,250mcg Retinol equivalent) (MDD) | |||
(2) External | |||||
Vitamin A Acetate | (1) Internal | (1) Equivalent to 7,500iu Vitamin A (2,250mcg Retinol equivalent) (MDD) | |||
(2) External | |||||
Vitamin A Palmitate | (1) Internal | (1) Equivalent to 7,500iu Vitamin A (2,250mcg Retinol equivalent) (MDD) | |||
(2) External | |||||
Warfarin | |||||
Warfarin Sodium | |||||
Xamoterol Fumarate | |||||
Xipamide | |||||
Yohimbine Hydrochloride | |||||
F46Zalcitabine | |||||
Zidovudine | |||||
Zimeldine Hydrochloride | |||||
Zolpidem Tartrate | |||||
Zomepirac Sodium | |||||
Zopiclone | |||||
Zuclopenthixol Acetate | |||||
Zuclopenthixol Decanoate | |||||
Zuclopenthixol Hydrochloride | |||||
F114SCHEDULE 2SUBSTANCES WHICH MAY BE EXCLUDED FROM THE CLASS OF PRESCRIPTION ONLY MEDICINES AT HIGH DILUTION
Sch. 2 substituted (1.5.2006) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2006 (S.I. 2006/915), arts. 1(1), 12
Codeine and its salts
Dihydrocodeine and its salts
Ethylmorphine and its salts
Morphine and its salts
Medicinal Opium
Pholcodine and its salts
SCHEDULE 3DESCRIPTIONS AND CLASSES OF PRESCRIPTION ONLY MEDICINES IN RELATION TO WHICH F115community practitioner nurse prescribers ARE APPROPRIATE PRACTITIONERS
Words in Sch. 3 heading substituted (1.5.2006) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2006 (S.I. 2006/915), arts. 1(1), 13
Words in Sch. 3 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 4
Words in Sch. 3 inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 14
F8Co-danthramer Capsules NPF
F8Co-danthramer Capsules, Strong NPF
Co-danthramer-Oral Suspension NPF
Co-danthramer-Oral Suspension Strong NPF
Co-danthrusate Capsules
F8Co-danthrusate Oral Suspension NPF
Mebendazole Tablets NPF
Mebendazole Oral Suspension NPF
Miconazole Oral Gel NPF
Nystatin Oral Suspension
Nystatin Pastilles NPF
Streptokinase and Streptodornase Topical Powder NPF
F89Water for Injections
F116SCHEDULE 3ACONTROLLED DRUGS WHICH MAY BE PRESCRIBED, ADMINISTERED OR DIRECTED FOR ADMINISTRATION BY NURSE INDEPENDENT PRESCRIBERS AND CONDITIONS FOR SUCH PRESCRIPTION OR ADMINISTRATION
Sch. 3A substituted (1.5.2006) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2006 (S.I. 2006/915), arts. 1(1), 14
Column 1 | Column 2 |
|---|---|
Substance | Requirements as to use or route of administration |
Buprenorphine | Transdermal administration in palliative care |
Chlordiazepoxide hydrochloride | Oral administration |
Codeine Phosphate | Oral administration |
Co-Phenotrope | Oral administration |
Diamorphine hydrochloride | Oral or parenteral administration |
Diazepam | Oral, parenteral or rectal administration |
Dihydrocodeine Tartrate | Oral administration |
Fentanyl | Transdermal administration in palliative care |
Lorazepam | Oral or parenteral administration |
Midazolam | Parenteral or buccal administration |
Morphine sulphate | Oral, parenteral or rectal administration |
Morphine hydrochloride | Rectal administration |
Oxycodone hydrochloride | Oral or parenteral administration in palliative care |
F90SCHEDULE 3BPARTICULARS FOR CLINICAL MANAGEMENT PLANS
Sch. 3B inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 16
A clinical management plan shall contain the following particulars—
a
the name of the patient to whom the plan relates;
b
the illnesses or conditions which may be treated by the supplementary prescriber;
c
the date on which the plan is to take effect and when it is to be reviewed by the doctor or dentist who is a party to the plan;
d
reference to the class or description of medicinal product which may be prescribed or administered under the plan;
e
any restrictions or limitations as to the strength or dose of any product which may be prescribed or administered under the plan, and any period of administration or use of any medicinal product which may be prescribed or administered under the plan;
f
relevant warnings about the known sensitivities of the patient to, or known difficulties of the patient with, particular medicinal products;
g
the arrangements for notification of—
i
suspected or known adverse reactions to any medicinal product which may be prescribed or administered under the plan, and
ii
suspected or known adverse reactions to any other medicinal product taken at the same time as any medicinal product prescribed or administered under the plan; and
h
the circumstances in which the supplementary prescriber should refer to, or seek the advice of, the doctor or dentist who is a party to the plan.
SCHEDULE 4SUBSTANCES NOT TO BE CONTAINED IN A PRESCRIPTION ONLY MEDICINE SOLD OR SUPPLIED UNDER THE EXEMPTION CONFERRED BY ARTICLE 8(3)
Ammonium Bromide
Calcium Bromide
Calcium Bromidolactobionate
Embutramide
Fencamfamin Hydrochloride
Fluanisone
Hexobarbitone
Hexobarbitone Sodium
Hydrobromic Acid
Meclofenoxate Hydrochloride
Methohexitone Sodium
Pemoline
Piracetam
Potassium Bromide
Prolintane Hydrochloride
Sodium Bromide
Strychnine Hydrochloride
Tacrine Hydrochloride
Thiopentone Sodium
SCHEDULE 5EXEMPTION FOR CERTAIN PERSONS FROM SECTION 58(2) OF THE ACT
PART IEXEMPTION FROM RESTRICTIONS ON SALE OR SUPPLY
Word in Sch. 5 Pt. 1 para. 4 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 4(a)
Words in Sch. 5 Pt. 1 para. 5 omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 8(a)
Words in Sch. 5 Pt. 1 para. 5 inserted (7.4.2005) by The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 8(b)
Words in Sch. 5 Pt. 1 omitted (7.4.2005) by virtue of The Medicines for Human Use (Prescribing) Order 2005 (S.I. 2005/765), arts. 1(1), 8(c)
Words in Sch. 5 Pt. 1 para. 5 omitted (30.6.2005) by virtue of The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (S.I. 2005/1507), arts. 1(1), 7(1)(a)
Words in Order substituted (30.6.2005 as notified in the London Gazette dated 3.6.2005) by The Opticians Act 1989 (Amendment) Order 2005 (S.I. 2005/848), Sch. 1 para. 27(b)
Words in Order substituted (30.6.2005 as notified in the London Gazette dated 3.6.2005) by The Opticians Act 1989 (Amendment) Order 2005 (S.I. 2005/848), Sch. 1 para. 27(b)
Sch. 5 Pt. 1 paras. 6A, 6B inserted (30.6.2005) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (S.I. 2005/1507), arts. 1(1), 7(1)(b)
Words in Sch. 5 Pt. 1 Table inserted (6.1.2006) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) (No. 2) Order 2005 (S.I. 2005/3324), arts. 1(1), 3
Sch. 5 Pt. 1 para. 10 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), art. 1, Sch.
Words in Sch. 5 Pt. 1 para. 10 substituted (17.11.2006) by The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 (S.I. 2006/2807), arts. 1(1), 4(2)(a)
Word in Sch. 5 Pt. 1 para. 10 omitted (17.11.2006) by virtue of The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 (S.I. 2006/2807), arts. 1(1), 4(2)(b)(i)
Words in Sch. 5 Pt. 1 para. 10 substituted (17.11.2006) by The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 (S.I. 2006/2807), arts. 1(1), 4(2)(b)(ii)
Column 1 | Column 2 | Column 3 |
|---|---|---|
Persons exempted | Prescription only medicines to which the exemption applies | Conditions |
1. Persons selling or supplying prescription only medicines to universities, other institutions concerned with higher education or institutions concerned with research. | 1. All prescription only medicines |
|
| 2. All prescription only medicines. | 2. The sale or supply shall be subject to the presentation of an order signed by or on behalf of any person listed in column 1 of this paragraph stating the status of the person signing it and the amount of prescription only medicine required, and shall be only in connection with the exercise by those persons of their statutory functions. |
3. Persons selling or supplying prescription only medicines to any person employed or engaged in connection with a scheme for testing the quality and checking the amount of the drugs and appliances supplied under the National Health Service Act 197723, the National Health Service (Scotland) Act 197824 and the Health and Personal Social Services (Northern Ireland) Order 197225, or under any subordinate legislation made under those Acts or that Order. | 3. All prescription only medicines. |
|
4. Registered midwives. |
| 4. The sale or supply shall be only in the course of their professional practice and in the case of Ergometrine maleate only when contained in a medicinal product which is not for parenteral administration. |
5. Persons lawfully conducting a retail pharmacy business within the meaning of section 69. |
| 5. The sale or supply shall be subject to the presentation of an order signed by a F110registered optometrist. |
6. F111Registered optometrists | 6. Prescription only medicines listed in column 2 of paragraph 5. |
|
F1076A Persons lawfully conducting a retail pharmacy business within the meaning of section 69. | Homotropine hydrobromide Ketotifen Levocabastine Lodoxamide Nedocromil sodium Olopatadine Pilocarpine hydrochloride F113Pilocarpine nitrate Polymyxin B/bacitracin Polymyxin B/trimethoprim Sodium cromoglycate. | The sale or supply shall be subject to the presentation of an order signed by an additional supply optometrist. |
6B Additional supply optometrists. | Prescription only medicines specified in column 2 of paragraph 6A. | The sale or supply shall be only—
|
7. Persons selling or supplying prescription only medicines to the British Standards Institution. | 7. All prescription only medicines. |
|
8. Holders of marketing authorizations, product licences or manufacturer’s licences. | 8. Prescription only medicines referred to in the authorizations or licences. |
|
9. Pharmacists selling or supplying to persons to whom cyanide salts may be sold by virtue of section 3 (regulation of poisons) or section 4 (exclusion of sales by wholesale and certain other sales) of the Poisons Act 197226 or by virtue of article 5 (prohibitions and regulations with respect to sale of poisons) or article 6 (exemption with respect to certain sales) of the Poisons (Northern Ireland) Order 197627. | 9. Amyl nitrite. | 9. The sale or supply shall only be so far as is necessary to enable an antidote to be available to persons at risk of cyanide poisoning. |
|
|
PART IIEXEMPTIONS FROM THE RESTRICTION ON SUPPLY
Sch. 5 Pt. 2 para. 3A inserted (30.6.2005) by The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (S.I. 2005/1507), arts. 1(1), 7(2)
Column 1 | Column 2 | Column 3 |
|---|---|---|
Persons exempted | Prescription only medicines to which the exemption applies | Conditions |
1. Royal National Lifeboat Institution and certified first aiders of the Institution. | 1. All prescription only medicines. | 1. The supply shall be only so far as is necessary for the the treatment of sick or injured persons in the exercise of the functions of the Institution. |
2. The owner or the master of a ship which does not carry a doctor on board as part of her complement. | 2. All prescription only medicines. | 2. The supply shall be only so far as is necessary for the treatment of persons on the ship. |
3. Persons authorized by licences granted under regulation 5 of the Misuse of Drugs Regulations to supply a controlled drug. | 3. Such prescription only medicines, being controlled drugs, as are specified in the licence. | 3. The supply shall be subject to such conditions and in such circumstances and to such an extent as may be specified in the licence. |
F1093A. Persons employed or engaged in the provision of lawful drug treatment services. | 3A. Ampoules of sterile water for injection containing not more than 2 ml of sterile water. | 3A. The supply shall be only in the course of provision of lawful drug treatment services. |
4. Persons requiring prescription only medicines for the purpose of enabling them, in the course of any business carried on by them, to comply with any requirements made by or in pursuance of any enactment with respect to the medical treatment of their employees. | 4. Such prescription only medicines as may be specified in the relevant enactment. |
|
5. Persons operating an occupational health scheme. | 5. Prescription only medicines sold or supplied to a person operating an occupational health scheme in response to an order in writing signed by a doctor or a registered nurse. |
|
6. The operator or commander of an aircraft. | 6. Prescription only medicines which are not for parenteral administration and which have been sold or supplied to the operator or commander of the aircraft in response to an order in writing signed by a doctor. | 6. The supply shall be only so far as is necessary for the immediate treatment of sick or injured persons on the aircraft and shall be in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used on the aircraft. |
7. Persons employed as qualified first-aid personnel on offshore installations. | 7. All prescription only medicines. | 7. The supply shall be only so far as is necessary for the treatment of persons on the installation. |
F1218. Persons who hold a certificate in first aid from the Mountain Rescue Council of England and Wales, or from the Northern Ireland Mountain Rescue Co-ordinating Committee. | 8 Prescription only medicines supplied to a person specified in column 1 in response to an order in writing signed by a doctor. | 8 The supply shall be only so far as is necessary for the treatment of sick or injured persons in the course of providing mountain rescue services. |
PART IIIEXEMPTIONS FROM RESTRICTION ON ADMINISTRATION Column 1
Words in Sch. 5 Pt. 3 para. 1 substituted (17.11.2006) by The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 (S.I. 2006/2807), arts. 1(1), 4(4)(a)
Words in Sch. 5 Pt. 3 para. 1 inserted (17.11.2006) by The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 (S.I. 2006/2807), arts. 1(1), 4(4)(b)
Words in Sch. 5 Pt. 3 substituted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 5(2)
Words in Sch. 5 Pt. 3 para. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 4(b)
Words in Sch. 5 Pt. 3 para. 2 inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 4
Words in Sch. 5 Pt. 3 para. 9 added (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 5(a)
Word in Sch. 5 Pt. 3 para. 9 substituted for words (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(3)(b)(ii)
Words in Sch. 5 Pt. 3 para. 9 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 5(b)
Word in Sch. 5 Pt. 3 para. 9 inserted (19.11.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2004 (S.I. 2004/2693), arts. 1(1), 6
Words in Sch. 5 Pt. 3 para. 9 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 5(c)
Words in Sch. 5 Pt. 3 para. 9 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 3
Words in Sch. 5 Pt. 3 para. 9 inserted (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 4
Column 1 | Column 2 | Column 3 |
|---|---|---|
Persons exempted | Prescription only medicines to which the exemption applies | Conditions |
F1221. Registered chiropodists against whose names are recorded in the relevant register annotations signifying that they are qualified to use the medicines specified in column 2.. |
| 1. The administration shall be only in the course of their professional practice. |
2. Registered midwives. |
| 2. The administration shall be only in the course of their professional practice and in the case of Promazine hydrochloride, Lignocaine and Lignocaine hydrochloride shall be only while attending on a woman in childbirth. |
3. Persons who are authorized as members of a group by a group authority granted under regulations 8(3) or 9(3) of the Misuse of Drugs Regulations to supply a controlled drug by way of administration only. | 3. Prescription only medicines that are specified in the group authority. | 3. The administration shall be subject to such conditions and in such circumstances and to such extent as may be specified in the group authority. |
4. The owner or master of a ship which does not carry a doctor on board as part of her complement. | 4. All prescription only medicines that are for parenteral administration. | 4. The administration shall be only so far as is necessary for the treatment of persons on the ship. |
5. Persons operating an occupational health scheme. | 5. Prescription only medicines for parenteral administration sold or supplied to the person operating an occupational health scheme in response to an order in writing signed by a doctor or a registered nurse. |
|
6. The operator or commander of an aircraft. | 6. Prescription only medicines for parenteral administration which have been sold or supplied to the operator or commander of the aircraft in response to an order in writing signed by a doctor. | 6. The administration shall be only so far as is necessary for the immediate treatment of sick or injured persons on the aircraft and shall be in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used on the aircraft. |
7. Persons who are, and at 11th February 1982 were, persons customarily administering medicinal products to human beings by parenteral administration in the course of a business in the field of osteopathy, naturopathy, acupuncture or other similar field except chiropody. | 7. Medicinal products that are prescription only medicines by reason only that they fall within the class specified in article 3(c) (products for parenteral administration). | 7. The person administering the prescription only medicine shall have been requested by or on behalf of the person to whom it is administered and in that person’s presence to use his own judgement as to the treatment required. |
8. Persons employed as qualified first-aid personnel on offshore installations. | 8. All prescription only medicines that are for parenteral administration. | 8. The administration shall be only so far as is necessary for the treatment of persons on the installation. |
9. Persons who hold a certificate of proficiency in ambulance paramedic skills issued by, or with the approval of, the Secretary of State F65or persons who are F95registered paramedics. |
| 9. The administration shall be only for the immediate, necessary treatment of sick or injured persons and in the case of a prescription only medicine containing Heparin Sodium shall be only for the purpose of cannula flushing. |
SCHEDULE 6ORDERS REVOKED
Column 1 | Column 2 |
|---|---|
Orders | References |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Order 1983 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1984 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1986 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1987 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1987 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1988 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1991 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1992 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1992 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1993 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1993 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1994 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1994 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 3) Order 1994 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1995 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1995 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1996 | |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1996 |
F50SCHEDULE 7
Sch. 7 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 2(e)
PART IPARTICULARS TO BE INCLUDED IN A PATIENT GROUP DIRECTION
a
the period during which the Direction shall have effect;
b
the description or class of prescription only medicine to which the Direction relates;
c
whether there are any restrictions on the quantity of medicine which may be supplied on any one occasion, and, if so, what restrictions;
d
the clinical situations which prescription only medicines of that description or class may be used to treat;
e
the clinical criteria under which a person shall be eligible for treatment;
f
whether any class of person is excluded from treatment under the Direction and, if so, what class of person;
g
whether there are circumstances in which further advice should be sought from a doctor or dentist and, if so, what circumstances;
h
the pharmaceutical form or forms in which prescription only medicines of that description or class are to be administered;
i
the strength, or maximum strength, at which prescription only medicines of that description or class are to be administered;
j
the applicable dosage or maximum dosage;
k
the route of administration;
l
the frequency of administration;
m
any minimum or maximum period of administration applicable to prescription only medicines of that description or class;
n
whether there are any relevant warnings to note, and, if so, what warnings;
o
whether there is any follow up action to be taken in any circumstances, and, if so, what action and in what circumstances;
p
arrangements for referral for medical advice;
q
details of the records to be kept of the supply, or the administration, of medicines under the Direction.
PART IIPERSONS ON WHOSE BEHALF A PATIENT GROUP DIRECTION MUST BE SIGNED
Words in Sch. 7 Pt. 2 inserted (1.10.2002) by The National Health Service Reform and Health Care Professions Act 2002 (Supplementary, Consequential etc. Provisions) Regulations 2002 (S.I. 2002/2469), reg. 1, Sch. 1 para. 73(4)
Words in Sch. 7 Pt. 2 inserted (1.4.2004) by The Health and Social Care (Community Health and Standards) Act 2003 (Supplementary and Consequential Provision) (NHS Foundation Trusts) Order 2004 (S.I. 2004/696), arts. 1(1)(b), 3(2), Sch. 2
Column 1 | Column 2 |
|---|---|
Class of person by whom a prescription only medicine is supplied or administered | Person on whose behalf the Direction must be signed |
Common Services Agency | The Agency |
F88Strategic Health Authority | F88The Strategic Health Authority |
Health Authority | The Health Authority |
Special Health Authority | The Special Health Authority |
NHS trust F97or NHS foundation trust | The trust |
Primary Care Trust | The Trust |
A person who supplies or administers a prescription only medicine pursuant to an arrangement made with the Common Services Agency, a Health Authority, a Special Health Authority, an NHS trust, F99, an NHS foundation trust or a Primary Care Trust | The Common Services Agency, where the arrangement has been made with the Agency; or the Health Authority, Special Health Authority, NHS trust F98or NHS foundation trust or Primary Care Trust with which the arrangement has been made |
F91PART IIAPERSONS BY WHOM OR ON WHOSE BEHALF A PATIENT GROUP DIRECTION USED IN THE PROVISION OF HEALTH CARE BY OR ON BEHALF OF THE POLICE, THE PRISON SERVICES OR THE ARMED FORCES MUST BE SIGNED
Sch. 7 Pt. 2A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 17
Column 1 Force or service by whom or on whose behalf the health care is provided | Column 2 Person by whom or on whose behalf the Direction must be signed |
|---|---|
A police force in England or Wales | The chief officer of police for that police force (within the meaning of the Police Act 1996) |
A police force in Scotland | The chief constable of that police force (within the meaning of the Police (Scotland) Act 1997) |
The Police Service of Northern Ireland | The Chief Constable of the Police Service of Northern Ireland |
The prison service in England and Wales | The governor of the prison in relation to which the health care in question is being provided |
The prison service in Scotland | The Scottish Prison Service Management Board |
The prison service in Northern Ireland | The Northern Ireland Prison Service Management Board |
Her Majesty’s Forces |
|
PART IIICLASSES OF INDIVIDUAL F51BY WHOM PRESCRIPTION ONLY MEDICINES MAY BE SUPPLIED OR ADMINISTERED
Words in Sch. 7 Pt. 3 heading substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 3(2)
Words in Sch. 7 Pt. 3 substituted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(4)(a)
Words in Sch. 7 Pt. 3 omitted (1.8.2004) by virtue of The Health Act 1999 (Consequential Amendments) (Nursing and Midwifery) Order 2004 (S.I. 2004/1771), art. 1(1), Sch. para. 39(b)
Words in Order substituted (30.6.2005 as notified in the London Gazette dated 3.6.2005) by The Opticians Act 1989 (Amendment) Order 2005 (S.I. 2005/848), Sch. 1 para. 27(b)
Word in Sch. 7 Pt. 3 substituted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(4)(b)
Words in Sch. 7 Pt. 3 substituted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(4)(c)
Words in Sch. 7 Pt. 3 added (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 5
F92Registered paramedics or individuals who hold a certificate of proficiency in ambulance paramedic skills issued by, or with the approval of, the Secretary of State.
Pharmacists.
F102...
Registered midwives.
Registered nurses.
F112Registered optometrists
F93Registered chiropodists.
F94Registered orthoptists.
Registered physiotherapists.
Registered radiographers.
F101“Registered dietitians.”;
F101“Registered occupational therapists.”;
F101“Registered orthotists and prosthetists.”; and
F101“Registered speech and language therapists.”
Words in Sch. 1 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 3(c)